Novavax | NVAX - Loan Capital

Stock Price
8.70
Daily Change
0.28 3.33%
Monthly
6.23%
Yearly
6.23%
Q1 Forecast
8.43

Novavax reported $223.63M in Loan Capital for its fiscal quarter ending in September of 2024.





Loan Capital Change Date
Adma Biologics USD 70.08M 3.32M Sep/2025
Agenus USD 23.6M 448K Sep/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BioCryst Pharmaceuticals USD 194.37M 48.43M Sep/2025
Cassava Sciences USD 0 0 Dec/2024
Geron USD 119.26M 273K Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
MannKind USD 303.65M 72.94M Sep/2025
Merck USD 39.97B 6B Sep/2025
Minerva Neurosciences USD 0 86.58M Sep/2024
Moderna USD 610M 584M Dec/2025
Novartis USD 24.24B 174M Sep/2025
Novavax USD 223.63M 187K Sep/2024
Pfizer USD 57.41B 93M Sep/2025
Sanofi EUR 15.72B 2.45B Dec/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
TG Therapeutics USD 245.34M 303K Sep/2025